Press Releases
ERIC Status for EU-OPENSCREEN
EU-OPENSCREEN ERIC is officially announced in the European Official Journal of the EU. The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is involved in the setting up of the infrastructure in Germany, which is funded by the Federal Ministry of (...)[more]
Start-up Tubulis Technologies erhält Leibniz-Gründerpreis 2018
Das gemeinsame Gründungsvorhaben Tubulis Technologies des Leibniz-Forschungsinstituts für Molekulare Pharmakologie (FMP) und der Ludwig-Maximilians-Universität München (LMU) ist mit dem Gründerpreis der Leibniz-Gemeinschaft 2018 ausgezeichnet worden. Die Gründer (...)[more]
How to Overcome the Blood Brain Barrier
The blood brain barrier is a mighty obstacle. Some substances in the blood are toxic to the sensitive brain. The barrier protects the brain and prevents these substances from crossing into the brain environment. While this is of great benefit, the barrier also (...)[more]
A Matter of Dynamics
Most ion channels are very selective about the ions, which may or may not pass through them. They may be conductive for potassium ions and non-conductive for sodium ions or vice versa. However, a number of ion channels allows for the efficient passage of both (...)[more]
How a Mutated Gene Triggers Hypertension
Arterial hypertension (high blood pressure) can occur when the adrenal cortex produces excess aldosterone hormone. How does this happen? Scientists working at the Leibniz Institute for Molecular Pharmacology (FMP) and the Max Delbrück Center for Molecular (...)[more]
Molecular Chaperones Shown to Assist in the Fight against Huntington Disease
Huntington’s disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put a stop to the insidious disintegration of brain cells. Fortunately, scientists of the (...)[more]
Volker Haucke is a new member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW)
Volker Haucke is a newly elected member of the Berlin-Brandenburg Academy of Sciences and Humanities. In their board sessions on Einstein Day 2017, the members of the BBAW elected Volker Haucke full member of the academy. [more]
Making a Super-TARP for Super-activation
Biophysicist Professor Dr. Andrew Plested works at the Leibniz Institute for Molecular Pharmacology in Berlin (Germany). He is hot on the trail of a new mechanism of the synaptic function. Last year, Professor Plested's group was able to demonstrate the (...)[more]
The point of release is the key: Identification of a key molecule for the neurotransmitter release in synapses
The contact areas between nerve cells are called synapses. What happens there lies at the heart of communication between nerve cells. Communication starts with the release of chemical messengers known as neurotransmitters at these synapses. (...)[more]
Toward New Antiviral Drugs and Antibiotics
Scientists at Freie Universität Berlin and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have succeeded in revealing a key mechanism of membrane deformation. “This mechanism plays a fundamental role in cell entry of receptors and hormones and (...)[more]
